Orehova M, Plavec J, Kocman V
ACS Omega. 2024; 9(6):7215-7229.
PMID: 38371751
PMC: 10870306.
DOI: 10.1021/acsomega.3c09592.
Zhou Y, Li X, Shen R, Wang X, Zhang F, Liu S
Front Immunol. 2022; 13:884399.
PMID: 35693820
PMC: 9186491.
DOI: 10.3389/fimmu.2022.884399.
Verma A, Tsao N, Thomann L, Ho Y, Iyengar S, Luoh S
PLoS Genet. 2022; 18(4):e1010113.
PMID: 35482673
PMC: 9049369.
DOI: 10.1371/journal.pgen.1010113.
van de Schoor F, Vrijmoeth H, Brouwer M, Ter Hofstede H, Lemmers H, Dijkstra H
Infect Immun. 2022; 90(3):e0055821.
PMID: 35130450
PMC: 8929378.
DOI: 10.1128/iai.00558-21.
Pellenz F, Dieter C, Lemos N, Bauer A, Marmontel de Souza B, Crispim D
Genet Mol Biol. 2021; 44(2):e20200425.
PMID: 33949620
PMC: 8097517.
DOI: 10.1590/1678-4685-GMB-2020-0425.
Exome-Wide Search for Genes Associated With Central Nervous System Inflammatory Demyelinating Diseases Following CHIKV Infection: The Tip of the Iceberg.
Alves-Leon S, Dos Santos Ferreira C, Herlinger A, Fontes-Dantas F, Rueda-Lopes F, da Silva Francisco Jr R
Front Genet. 2021; 12:639364.
PMID: 33815474
PMC: 8010313.
DOI: 10.3389/fgene.2021.639364.
Immunology of IL-12: An update on functional activities and implications for disease.
Ullrich K, Schulze L, Paap E, Muller T, Neurath M, Zundler S
EXCLI J. 2021; 19:1563-1589.
PMID: 33408595
PMC: 7783470.
DOI: 10.17179/excli2020-3104.
Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology.
Nayar S, Campos J, Smith C, Iannizzotto V, Gardner D, Mourcin F
Proc Natl Acad Sci U S A. 2019; 116(27):13490-13497.
PMID: 31213547
PMC: 6613169.
DOI: 10.1073/pnas.1905301116.
Single Nucleotide Polymorphism of Gene and Susceptibility to Rheumatoid Arthritis in Iranian Population.
Mohamadhosseini A, Mansouri R, Javinani A, Ganjouei A, Akhlaghi M, Aslani S
Avicenna J Med Biotechnol. 2019; 11(2):187-191.
PMID: 31057722
PMC: 6490405.
The -P1104A Autoimmune Protective Variant Limits Coordinate Signals Required to Generate Specialized T Cell Subsets.
Gorman J, Hundhausen C, Kinsman M, Arkatkar T, Allenspach E, Clough C
Front Immunol. 2019; 10:44.
PMID: 30740104
PMC: 6355696.
DOI: 10.3389/fimmu.2019.00044.
Identification of imidazo[1,2-]pyridazine TYK2 pseudokinase ligands as potent and selective allosteric inhibitors of TYK2 signalling.
Moslin R, Gardner D, Santella J, Zhang Y, Duncia J, Liu C
Medchemcomm. 2018; 8(4):700-712.
PMID: 30108788
PMC: 6071835.
DOI: 10.1039/c6md00560h.
Canonical and Non-Canonical Aspects of JAK-STAT Signaling: Lessons from Interferons for Cytokine Responses.
Majoros A, Platanitis E, Kernbauer-Holzl E, Rosebrock F, Muller M, Decker T
Front Immunol. 2017; 8:29.
PMID: 28184222
PMC: 5266721.
DOI: 10.3389/fimmu.2017.00029.
CD6 gene polymorphism rs17824933 is associated with multiple sclerosis in Indian population.
DCunha M, Pandit L, Malli C
Ann Indian Acad Neurol. 2016; 19(4):491-494.
PMID: 27994359
PMC: 5144471.
DOI: 10.4103/0972-2327.192384.
Neuroinflammation - using big data to inform clinical practice.
Dendrou C, McVean G, Fugger L
Nat Rev Neurol. 2016; 12(12):685-698.
PMID: 27857124
DOI: 10.1038/nrneurol.2016.171.
Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity.
Dendrou C, Cortes A, Shipman L, Evans H, Attfield K, Jostins L
Sci Transl Med. 2016; 8(363):363ra149.
PMID: 27807284
PMC: 5737835.
DOI: 10.1126/scitranslmed.aag1974.
Opportunities for Translation from the Bench: Therapeutic Intervention of the JAK/STAT Pathway in Neuroinflammatory Diseases.
Liu Y, Gibson S, Benveniste E, Qin H
Crit Rev Immunol. 2016; 35(6):505-27.
PMID: 27279046
PMC: 5328657.
DOI: 10.1615/CritRevImmunol.2016015517.
Multiple sclerosis: getting personal with induced pluripotent stem cells.
Di Ruscio A, Patti F, Welner R, Tenen D, Amabile G
Cell Death Dis. 2015; 6:e1806.
PMID: 26158512
PMC: 4650727.
DOI: 10.1038/cddis.2015.179.
The European Genome-phenome Archive of human data consented for biomedical research.
Lappalainen I, Almeida-King J, Kumanduri V, Senf A, Spalding J, Ur-Rehman S
Nat Genet. 2015; 47(7):692-5.
PMID: 26111507
PMC: 5426533.
DOI: 10.1038/ng.3312.
The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications.
Marinoni B, Ceribelli A, Massarotti M, Selmi C
Auto Immun Highlights. 2015; 5(1):9-19.
PMID: 26000152
PMC: 4389010.
DOI: 10.1007/s13317-013-0057-4.
Tyrosine Kinase 2-mediated Signal Transduction in T Lymphocytes Is Blocked by Pharmacological Stabilization of Its Pseudokinase Domain.
Tokarski J, Zupa-Fernandez A, Tredup J, Pike K, Chang C, Xie D
J Biol Chem. 2015; 290(17):11061-74.
PMID: 25762719
PMC: 4409266.
DOI: 10.1074/jbc.M114.619502.